Virtual Meeting to be held on February 20 hosted by BTIG.Discover the Best Stocks and Maximize Your Portfolio: See what stocks are receiving ...

Wells Fargo analyst Larry Biegelsen maintained a Buy rating on Dexcom (DXCM – Research Report) yesterday and set a price target of $98.00. The ...

DXCM earnings call for the period ending December 31, 2024.

Shares of DexCom Inc. DXCM slid 2.91% to $83.87 Wednesday, on what proved to be an all-around poor trading session for the ...

For people living with Type 1 Diabetes (T1D), keeping blood sugar levels in check is a constant challenge. A new clinical trial at UVA is aiming to simplify diabetes management by testing an ...

DexCom Inc. closed 39.17% below its 52-week high of $142.00, which the company reached on March 26th.

Continuous glucose monitors are small, wearable devices that track blood sugar levels in real-time. While the devices are commonly prescribed to diabetics to titrate medications (e.g. insulin) to ...